Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may have... CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today ...

But on the bright side, you can make far more than 100% on a really good stock. Long term Cencora, Inc. (NYSE:COR) shareholders would be well aware of this, since the stock is up 156% in five years.

How can pharmaceutical firms shore up their sustainability credentials at a time when the entire research landscape is turning on its head? A recent webinar from supply chain leaders World Courier and ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...

Cencora, Inc. has a 1-year low of $214.77 and a 1-year high of $262.26. The stock has a market cap of $46.97 billion, a price-to-earnings ratio of 34.57, a P/E/G ratio of 1.49 and a beta of 0.49.

Highlights,Institutional investors have increased their holdings in Cencora, demonstrating ongoing interest in the company.,The company operates within the healthcare distribution sector, offering ...